5-FU loaded pHEMA drainage implants for glaucoma-filtering surgery: device design and in vitro release kinetics

doi:10.1016/0142-9612(96)83290-X

Biomaterials

Volume 17, Issue 9, 1996, Pages 941-949

https://doi.org/10.1016/0142-9612(96)83290-X Get rights and content

Abstract

Implantable monolithic and reservoir-like water-swellable drainage devices were developed for the subconjunctival sustained release of 5-fluorouracil (5-FU) in glaucoma-filtering surgery. A water-swellable matrix was formed of a copolymer of 2-hydroxyethyl methacrylate (HEMA) with different amounts of ethylene glycol dimethacrylate (EGDMA). Drug incorporation was done before polymerization and cross-linking. Briefly, to prepare the monolithic device the monomer-drug mixture is compression moulded into a 10 mm cylinder of 1 mm length. Furthermore, reservoir-like devices were obtained by coating the monolithic devices with a highly cross-linked polymer of HEMA (pHEMA) composition. The pHEMA devices containing 5-FU or not were well characterized by means of dynamic swelling studies, structural and thermal analysis. The release of 5-FU from these implants was studied in vitro. The rate of drug release was controlled by changing the drug loading (i.e. 10 mg or 20 mg 5-FU per device), cross-linking density of polymer matrix and type of implantable device, i.e. monolithic or reservoir-like device. While monolithic devices are releasing total releasable 5-FU during the first 10 h, reservoir-like devices prolong 5-FU release for up to 120 h. The 5-FU diffusion coefficient in swollen devices (D_s,s) is in the order of 10⁻⁸ cm² s⁻¹ (approximately 10 times smaller than D_w,g values) and it is dependent on the cross-linking density of polymeric matrix and device load. These preliminary results suggested that 20 mg 5-FU-loaded reservoir-like devices may be a potentially effective system to deliver 5-FU into the subconjunctiva.

References (26)

S.S. Palmer
Mitomycin as adjunct chemotherapy with trabeculectomy
Ophthalmology
(1991)
D.K. Heuer et al.
5-Fluorouracil and glaucoma filtering surgery. II: A pilot study
Opthalmology
(1984)
G.L. Skuta et al.
Filtering surgery in owl monkeys treated with the antimetabolite 5-fluorouridine 5'-monophosphate entrapped in multivesicular liposoms
Am J Ophthalmol
(1987)
B Hasty et al.
Primate trabeculetomies with 5-fluorouracil collagen implants
Am J Ophthalmol
(1990)
A. Merkli et al.
Semi-solid hydrophobic bioerodible poly(ortho ester) for potential application in glaucoma filtering surgery
J Contr Rel
(1994)
A Denizli et al.
A subcutaneous polymeric matrix system poly(HEMA/BGA) for controlled release of anticancer drug (5-fluorouracil). I: Synthesis and structure
Biomaterials
(1988)
A Denizli et al.
A subcutaneous polymeric matrix system p(HEMA-BGA) for controlled release of an anticancer drug (5-fluorouracil). II: Release kinetics
Biomaterials
(1988)
R.H. Trigo et al.
Anticancer drug, ara-C, release from pHEMA hydrogels
Biomaterials
(1994)
A Apicella et al.
Poly(ethylene oxide) (PEO) and different molecular weight PEO blends monolithic devices for drug release
Biomaterials
(1993)
P.I. Lee
Kinetics of drug release from hydrogel matrices
J Contr Rel
(1985)

T Krupin et al.

Drainage implants

M.M. Wright et al.

Antimetabolites in filtering surgery

R.K. Parrish

Who should receive antimetabolites after filtering surgery?

Arch Ophthalmol

(1992)

Cited by (16)

Sustained prevention of biofilm formation on a novel silicone matrix suitable for medical devices
2015, European Journal of Pharmaceutics and Biopharmaceutics
Citation Excerpt :
Since this accounts for a large fraction of the total released amount of drug, the result is a poor fit. The diffusion coefficients are all in the range of 109 cm2/s, which is at least a factor of 10 lower than what has been previously reported in literature for diffusion of small molecules in HEMA-based hydrogels [25–27]. This reduction in Dapp can be expected as the matrix is considered to have a highly restricted and tortuous diffusion path when compared to PHEMA gels not incorporated into a matrix.
Bacterial colonization and biofilm formation on medical devices constitute major challenges in clinical long-term use of e.g. catheters due to the risk of (re)infection of patients, which would result in additional use of antibiotics risking bacterial resistance development. The aim of the present project was to introduce a novel antibacterial approach involving an advanced composite material applicable for medical devices. The polymeric composites investigated consisted of a hydrogel network of cross-linked poly(2-hydroxyethyl methacrylate) (PHEMA) embedded in a poly(dimethylsiloxane) (PDMS) silicone elastomer produced using supercritical carbon dioxide (scCO₂). In these materials, the hydrogel may contain an active pharmaceutical ingredient while the silicone elastomer provides the sufficient mechanical stability of the material. In these conceptual studies, the antimicrobial agent ciprofloxacin was loaded into the polymer matrix by a post-polymerization loading procedure. Sustained release of ciprofloxacin was demonstrated, and the release could be controlled by varying the hydrogel content in the range 13–38% (w/w) and by changing the concentration of ciprofloxacin during loading in the range of 1–20 mg/mL. Devices containing 25% (w/w) hydrogel and loaded with ciprofloxacin displayed a strong antibacterial effect against Staphylococcus aureus bacterial colonization and subsequent biofilm formation on the device material was inhibited for 29 days. In conclusion, the hydrogel/silicone composite represents a promising candidate material for medical devices that prevent bacterial colonization during long-term use.
Mechanisms of diphylline release from dual-solute loaded poly(vinyl alcohol) matrices
2014, Materials Science and Engineering C
Citation Excerpt :
Thus, even for the lowest diphylline load studied (2% w/w), the total solute initially present in the matrix is 13% w/w, and the measured equilibrium water uptake of the depleted matrix is distinctly higher than that of pure PVA and of PVA loaded solely with 2% diphylline (Table 1). Gökce et al. [38] report acceleration of release rate with increasing drug load in PHEMA matrices loaded with 5-fluoracil, although the Tg of the loaded matrix was found higher than that of the drug-free polymer. The said acceleration was correlated with the corresponding equilibrium water uptake of the matrices, which was also found to increase with increasing drug load.
The release kinetics of the model hydrophilic drug, diphylline (DPL), from physically crosslinked poly(vinyl alcohol) (PVA) matrices, is studied in relation to the drug load and the presence of a second solute incorporated in the matrix. The second solute, a gadolinium (III) complex (Gd-DTPA), is a commonly used MRI contrast agent. The water uptake kinetics by the glassy PVA matrix was found to deviate from t^1/2 law and to occur on time scales comparable to those of diphylline release. The corresponding rate of diphylline release was found to be substantially stabilized as compared to a purely diffusion-controlled release process, in line with theoretical predictions under conditions of relaxation-controlled water uptake kinetics. The release rate of DPL was found (i) to increase with increasing DPL load and (ii) for a particular DPL load, to increase in the presence of Gd-DTPA, incorporated in the matrix. The results were interpreted on the basis of the diphylline-induced plasticization of the polymer (evidenced by the depression of T_g) and of the excess hydration of the matrix at high solute loads. The latter effect was found to be additive in the case of dual-solute loaded matrices.
Molecular dynamics simulation study of P (VP-co-HEMA) hydrogels: Effect of water content on equilibrium structures and mechanical properties
2009, Biomaterials
Citation Excerpt :
Since the landmark development of poly (2-hydroxyethyl methacrylate) (PHEMA) in the early 1960s by Wichterle and Lim [4], various types of hydrogels have been studied intensively over the last 50 years as promising biomaterials for medical and pharmaceutical applications [5–12], including drug delivery and tissue engineering. PHEMA is one of the most important synthetic hydrogels that has been extensively developed in biomedical applications, and has been widely exploited for contact lenses [13] and drug delivery [14–17]. The utility of PHEMA is derived from its good mechanical properties, optical transparency and stability in water.
Poly (N-vinyl-2-pyrrolidone-co-2-hydroxyethyl methacrylate) (P(VP-co-HEMA)) hydrogel system with a composition of VP:HEMA = 37:13 was studied using molecular dynamics simulations in order to investigate the effect of the water content on the equilibrium structures and the mechanical properties. The degree of randomness of the monomer sequence for the random and the blocky copolymers, were 1.170 and 0.104, respectively, and the degree of polymerization was fixed at 50. The equilibrated density of the hydrogel was found to be larger for the random sequence than for the blocky sequence at low water contents (<40 wt%), but this density difference decreased with increasing water content. The pair correlation function analysis shows that VP is more hydrophilic than HEMA and that the random sequence hydrogel is solvated more than the blocky sequence hydrogel at low water content, which disappears with increasing water content. Correspondingly, the water structure is more disrupted by the random sequence hydrogel at low water content but eventually develops the expected bulk water-like structure with increasing water content. From mechanical deformation simulations, stress–strain analysis showed that the VP is found to relax more efficiently, especially in the blocky sequence, so that the blocky sequence hydrogel shows less stress levels compared to the random sequence hydrogel. As the water content increases, the stress level becomes identical for both sequences. The elastic moduli of the hydrogels calculated from the constant strain energy minimization show the same trend with the stress–strain analysis.
Diclofenac sodium releasing pH-sensitive monolithic devices
2002, International Journal of Pharmaceutics
A non-steroidal anti-inflammatory agent, diclofenac sodium (DFNa), was incorporated into the pH-sensitive monolithic systems prepared by crosslinking/copolymerization of 2-hydroxyethyl methacrylate (HEMA) with acrylate-based acidic and basic comonomers, i.e. acrylic acid (AA) and dimethylaminoethyl methacrylate (DMAEMA). Drug loading was done before polymerization and crosslinking. Hence, DFNa-containing polymeric discs approximately 10 mm in diameter and 3.0 mm in thickness were obtained. In vitro release studies were carried out in simulated gastric fluid for 3 h followed by simulated intestinal fluid at 37 °C. The release rate of DFNa was controlled by changing the composition of polymeric matrix, disc thickness and the drug loading between 5 and 33 mg/disc. Results indicate that in the low pH of the stomach, swelling degree of the AA-containing gels is low and less than 5% of the drug releases during first 3 h. But, in the intestine, the high pH causes the higher swelling degree of the AA-containing discs, allowing all the drug (∼97.5%) is released. In the presence of DMAEMA in polymeric structure, opposite behavior was observed.
Slow release of the antimetabolite 5-fluorouracil (5-FU) from modified Baerveldt glaucoma drains to prolong drain function
2001, Biomaterials
Drainage devices are routinely placed in the eyes of patients with glaucoma to reduce intraocular pressure (IOP) by providing controlled outflow of fluid (aqueous humor) via a filtering bleb. However, the natural wound healing response often interferes with fluid outflow by thickening the walls of the bleb over time, so that these devices rarely remain functional for more than 5 years. We investigated the use of controlled release of an antimetabolite, 5-fluorouracil (5-FU), within glaucoma drains to determine if the wound healing response could be reduced and the useful life span of the device increased. Collagen plugs containing 1.125 mg of 5-FU were placed in the silicone tubes of modified Baerveldt glaucoma drains. Eight drains with 5-FU and eight drains without 5-FU were implanted in one eye each of 16 New Zealand white rabbits; the contralateral eyes served as unoperated controls. Results were evaluated in terms of IOP, fibrous capsule thickness, macrophage density, and presence of type III collagen surrounding the drain plate, 3 and 6 months after implantation. In general, eyes implanted with antimetabolite-containing drains demonstrated significantly lower values for all evaluated parameters at 3 months and lower or equal values at 6 months, compared with the eyes not receiving 5-FU and the unoperated controls, indicating improved IOP-lowering function, reduced bleb wall thickness, and earlier achievement of a steady-state wound healing response. All eyes remained healthy throughout the 6-month duration of the study with no cytotoxicity complications in any of the eyes. Thus, biodegradable plugs placed within the silicone tubes of glaucoma drains can safely deliver 5-FU to filtering blebs over time, which could prolong the functional life of the bleb by decreasing the thickness of the anterior fibrous capsule and permitting sufficient fluid outflow to reduce IOP to physiological levels.
Synthesis of Porous Polymer with Biocompatible Sodium Alginate and 2-Hydroxyethyl Methacrylate Monomers in High Internal Emulsion as Drug Delivery Substrate in Releasing of Doxorubicin
2024, Chemical Methodologies

View all citing articles on Scopus

^*: A part of this study was presented at ARVO meeting, Saratosa, May 1994.

View full text

5-FU loaded pHEMA drainage implants for glaucoma-filtering surgery: device design and in vitro release kinetics*

Abstract

Ophthalmology

Opthalmology

Am J Ophthalmol

Am J Ophthalmol

J Contr Rel

Biomaterials

Biomaterials

Biomaterials

Biomaterials

J Contr Rel

Drainage implants

Antimetabolites in filtering surgery

Who should receive antimetabolites after filtering surgery?

Arch Ophthalmol